Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (SHE:300760)
China · Delayed Price · Currency is CNY 179.40
+1.89 (1.06%)
Nov 13, 2026, 3:04 PM CST
SHE:300760 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Equivalents | 19,360 | 17,690 | 16,644 | 18,787 | 23,186 | 15,361 |
Trading Asset Securities | 497.76 | 250.49 | - | - | - | - |
Cash & Short-Term Investments | 19,857 | 17,941 | 16,644 | 18,787 | 23,186 | 15,361 |
Cash Growth | 13.37% | 7.79% | -11.41% | -18.97% | 50.94% | -3.17% |
Accounts Receivable | 3,573 | 3,410 | 3,226 | 3,297 | 2,661 | 1,790 |
Other Receivables | 260.53 | 201.29 | 205.53 | 195.1 | 149.11 | 126.04 |
Receivables | 3,868 | 3,651 | 3,475 | 3,534 | 2,842 | 1,943 |
Inventory | 5,992 | 5,004 | 4,757 | 3,979 | 4,025 | 3,565 |
Prepaid Expenses | - | 139.69 | 59.71 | 60.57 | 92.31 | 58.1 |
Other Current Assets | 910.58 | 675.12 | 709.96 | 515.29 | 461.19 | 407.58 |
Total Current Assets | 30,628 | 27,410 | 25,647 | 26,875 | 30,606 | 21,335 |
Property, Plant & Equipment | 11,693 | 11,150 | 10,035 | 8,221 | 6,290 | 5,131 |
Long-Term Investments | 398.56 | 374.43 | 395.37 | 3,087 | 1,617 | 4,026 |
Goodwill | 11,030 | 11,404 | 11,093 | 5,062 | 4,403 | 4,218 |
Other Intangible Assets | 5,799 | 6,390 | 6,723 | 2,225 | 1,977 | 2,061 |
Long-Term Accounts Receivable | 16.29 | 17.47 | 22.86 | 10.94 | 25.28 | 34.55 |
Long-Term Deferred Tax Assets | 1,303 | 1,567 | 1,697 | 1,313 | 755.08 | 596.43 |
Long-Term Deferred Charges | 618.61 | 377.17 | 406 | 417.23 | 379.45 | 224.24 |
Other Long-Term Assets | 525.96 | 465.14 | 504.29 | 604 | 590.95 | 376.65 |
Total Assets | 62,012 | 59,267 | 56,644 | 47,940 | 46,745 | 38,103 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Accounts Payable | 4,282 | 3,242 | 2,793 | 2,690 | 2,291 | 2,281 |
Accrued Expenses | 2,561 | 3,515 | 3,596 | 3,049 | 3,136 | 2,428 |
Short-Term Debt | 0.17 | 0.33 | 5.4 | 7.75 | - | - |
Current Portion of Long-Term Debt | 125.27 | 0.46 | 1.16 | 0.43 | - | - |
Current Portion of Leases | - | 123.19 | 114.27 | 104.3 | 97.22 | 85.08 |
Current Income Taxes Payable | 464.97 | 213.66 | 205.43 | 471.65 | 287.22 | 256.75 |
Current Unearned Revenue | 3,427 | 3,001 | 2,166 | 1,974 | 4,143 | 2,408 |
Other Current Liabilities | 2,006 | 1,504 | 1,547 | 1,804 | 1,816 | 1,170 |
Total Current Liabilities | 12,866 | 11,600 | 10,427 | 10,103 | 11,770 | 8,629 |
Long-Term Debt | - | 4.06 | 0.34 | 1.38 | - | - |
Long-Term Leases | 175.26 | 221.24 | 177.31 | 181.07 | 139.31 | 152.15 |
Long-Term Unearned Revenue | 214.08 | 478.5 | 282.65 | 109.31 | 92.94 | 105.09 |
Long-Term Deferred Tax Liabilities | 642.35 | 712.62 | 808.7 | 168.36 | 183.13 | 200.44 |
Other Long-Term Liabilities | 2,023 | 3,239 | 4,189 | 4,031 | 2,561 | 2,048 |
Total Liabilities | 15,920 | 16,255 | 15,885 | 14,594 | 14,746 | 11,135 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Common Stock | 1,212 | 1,212 | 1,212 | 1,212 | 1,212 | 1,216 |
Additional Paid-In Capital | 5,791 | 6,081 | 6,752 | 7,091 | 7,509 | 8,153 |
Retained Earnings | 34,432 | 30,750 | 28,229 | 25,288 | 24,369 | 18,994 |
Treasury Stock | - | -210.57 | -337.77 | -663.28 | -999.99 | -999.99 |
Comprehensive Income & Other | -232.23 | 260.27 | 1.51 | 157.27 | -109.07 | -409.74 |
Total Common Equity | 41,203 | 38,093 | 35,856 | 33,085 | 31,981 | 26,953 |
Minority Interest | 4,889 | 4,918 | 4,902 | 260.65 | 18.29 | 15.24 |
Shareholders' Equity | 46,092 | 43,011 | 40,758 | 33,346 | 31,999 | 26,968 |
Total Liabilities & Equity | 62,012 | 59,267 | 56,644 | 47,940 | 46,745 | 38,103 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Total Debt | 300.71 | 349.28 | 298.49 | 294.93 | 236.52 | 237.24 |
Net Cash (Debt) | 19,557 | 17,592 | 16,346 | 18,492 | 22,949 | 15,124 |
Net Cash Growth | 13.99% | 7.62% | -11.61% | -19.42% | 51.74% | -4.67% |
Net Cash Per Share | 16.14 | 14.52 | 13.49 | 15.26 | 18.96 | 12.45 |
Filing Date Shares Outstanding | 1,212 | 1,212 | 1,210 | 1,214 | 1,209 | 1,213 |
Total Common Shares Outstanding | 1,212 | 1,212 | 1,210 | 1,214 | 1,209 | 1,213 |
Working Capital | 17,762 | 15,811 | 15,219 | 16,773 | 18,836 | 12,706 |
Book Value Per Share | 34.00 | 31.44 | 29.64 | 27.25 | 26.44 | 22.23 |
Tangible Book Value | 24,373 | 20,299 | 18,040 | 25,799 | 25,601 | 20,673 |
Tangible Book Value Per Share | 20.11 | 16.75 | 14.91 | 21.25 | 21.17 | 17.05 |
Land | - | 6,460 | 5,978 | 4,799 | 3,662 | 3,259 |
Machinery | - | 4,822 | 4,149 | 3,283 | 2,822 | 2,366 |
Construction In Progress | - | 3,154 | 2,675 | 2,461 | 1,803 | 1,126 |